25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TMDX (Transmedics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Transmedics together

I guess you are interested in TransMedics Group Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Transmedicsโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Transmedicsโ€™s Price Targets

I'm going to help you getting a better view of TransMedics Group Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about TransMedics Group Inc

I send you an email if I find something interesting about TransMedics Group Inc.

1. Quick Overview

1.1. Quick analysis of Transmedics (30 sec.)










1.2. What can you expect buying and holding a share of Transmedics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$7.84
Expected worth in 1 year
$10.30
How sure are you?
35.3%

+ What do you gain per year?

Total Gains per Share
$2.46
Return On Investment
2.1%

For what price can you sell your share?

Current Price per Share
$119.15
Expected price per share
$98.88 - $145.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Transmedics (5 min.)




Live pricePrice per Share (EOD)
$119.15
Intrinsic Value Per Share
$94.57 - $115.02
Total Value Per Share
$102.41 - $122.87

2.2. Growth of Transmedics (5 min.)




Is Transmedics growing?

Current yearPrevious yearGrowGrow %
How rich?$318.1m$153.2m$102.4m40.1%

How much money is Transmedics making?

Current yearPrevious yearGrowGrow %
Making money$17.9m$750k$17.1m95.8%
Net Profit Margin12.4%-2.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Transmedics (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#75 / 289

Most Revenue
#60 / 289

Most Profit
#45 / 289
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Transmedics?

Welcome investor! Transmedics's management wants to use your money to grow the business. In return you get a share of Transmedics.

First you should know what it really means to hold a share of Transmedics. And how you can make/lose money.

Speculation

The Price per Share of Transmedics is $119.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Transmedics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Transmedics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $7.84. Based on the TTM, the Book Value Change Per Share is $0.62 per quarter. Based on the YOY, the Book Value Change Per Share is $0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Transmedics.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.860.7%0.450.4%0.020.0%0.110.1%-0.050.0%-0.11-0.1%
Usd Book Value Change Per Share1.171.0%0.620.5%0.280.2%0.530.4%0.230.2%0.230.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.171.0%0.620.5%0.280.2%0.530.4%0.230.2%0.230.2%
Usd Price Per Share134.01-105.16-89.56-86.84-63.05-40.08-
Price to Earnings Ratio38.93-119.33-77.62--24.85--24.95--17.58-
Price-to-Total Gains Ratio114.45-226.05-119.63--211.73--176.70--149.74-
Price to Book Ratio17.09-15.87-19.62-16.16-14.61-10.15-
Price-to-Total Gains Ratio114.45-226.05-119.63--211.73--176.70--149.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share119.15
Number of shares8
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.620.23
Usd Total Gains Per Share0.620.23
Gains per Quarter (8 shares)4.921.80
Gains per Year (8 shares)19.697.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10201007-3
2039300144
30595002211
40797002918
50989003625
6011811004332
7013813005039
8015815005846
9017717006553
10019719007260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%7.05.00.058.3%7.013.00.035.0%7.027.00.020.6%7.027.00.020.6%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%9.011.00.045.0%12.018.04.035.3%12.018.04.035.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%9.011.00.045.0%12.018.04.035.3%12.018.04.035.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of TransMedics Group Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1710.615+90%0.280+318%0.529+121%0.225+420%0.231+408%
Book Value Per Share--7.8436.723+17%4.426+77%5.459+44%4.240+85%2.821+178%
Current Ratio--9.8578.864+11%9.831+0%10.616-7%9.719+1%7.343+34%
Debt To Asset Ratio--0.6430.693-7%0.788-18%0.640+0%0.550+17%0.541+19%
Debt To Equity Ratio--1.7992.301-22%3.782-52%2.460-27%1.777+1%1.912-6%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--5263459291.5303750302017.470+40%2928429993.533+80%3004444301.001+75%2194262665.401+140%1903272460.320+177%
Eps--0.8610.454+89%0.017+4855%0.114+657%-0.046+105%-0.110+113%
Ev To Ebitda Ratio--28.36644.476-36%36.470-22%-968.525+3514%-594.125+2195%-480.312+1793%
Ev To Sales Ratio--8.3627.230+16%7.882+6%10.254-18%17.817-53%21.021-60%
Free Cash Flow Per Share--2.0350.075+2619%-1.614+179%-0.613+130%-0.485+124%-0.371+118%
Free Cash Flow To Equity Per Share--2.2100.201+999%-1.498+168%0.850+160%0.396+458%0.311+610%
Gross Profit Margin--1.0000.988+1%0.908+10%1.309-24%1.196-16%1.128-11%
Intrinsic Value_10Y_max--115.024----------
Intrinsic Value_10Y_min--94.567----------
Intrinsic Value_1Y_max---0.429----------
Intrinsic Value_1Y_min---0.428----------
Intrinsic Value_3Y_max--7.823----------
Intrinsic Value_3Y_min--7.284----------
Intrinsic Value_5Y_max--27.059----------
Intrinsic Value_5Y_min--24.331----------
Market Cap4061871160.000-34%5435305291.5303979628267.470+37%3110871243.533+75%3111130717.668+75%2239951265.401+143%1419638926.706+283%
Net Profit Margin--0.2220.124+79%-0.025+111%-0.016+107%-0.456+305%-1.072+583%
Operating Margin--0.2520.146+72%-0.005+102%0.010+2504%-0.395+257%-0.976+487%
Operating Ratio--0.7680.867-11%1.039-26%1.010-24%1.405-45%1.970-61%
Pb Ratio15.192-12%17.08715.866+8%19.623-13%16.156+6%14.613+17%10.146+68%
Pe Ratio34.611-12%38.927119.330-67%77.621-50%-24.853+164%-24.950+164%-17.576+145%
Price Per Share119.150-12%134.010105.160+27%89.560+50%86.838+54%63.052+113%40.082+234%
Price To Free Cash Flow Ratio14.638-12%16.46412.686+30%160.701-90%35.713-54%10.589+55%3.046+440%
Price To Total Gains Ratio101.761-12%114.452226.046-49%119.631-4%-211.734+285%-176.699+254%-149.741+231%
Quick Ratio--8.9277.827+14%8.763+2%9.568-7%10.747-17%8.349+7%
Return On Assets--0.0390.021+87%0.000+8860%0.002+1892%-0.028+171%-0.052+233%
Return On Equity--0.1100.064+71%-0.008+107%0.011+918%-0.047+143%-0.158+244%
Total Gains Per Share--1.1710.615+90%0.280+318%0.529+121%0.225+420%0.231+408%
Usd Book Value--318101000.000255733000.000+24%153256750.000+108%195752416.667+63%150318000.000+112%99561411.765+220%
Usd Book Value Change Per Share--1.1710.615+90%0.280+318%0.529+121%0.225+420%0.231+408%
Usd Book Value Per Share--7.8436.723+17%4.426+77%5.459+44%4.240+85%2.821+178%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--5263459291.5303750302017.470+40%2928429993.533+80%3004444301.001+75%2194262665.401+140%1903272460.320+177%
Usd Eps--0.8610.454+89%0.017+4855%0.114+657%-0.046+105%-0.110+113%
Usd Free Cash Flow--82534000.0004338000.000+1803%-55242000.000+167%-20366500.000+125%-16205100.000+120%-12453764.706+115%
Usd Free Cash Flow Per Share--2.0350.075+2619%-1.614+179%-0.613+130%-0.485+124%-0.371+118%
Usd Free Cash Flow To Equity Per Share--2.2100.201+999%-1.498+168%0.850+160%0.396+458%0.311+610%
Usd Market Cap4061871160.000-34%5435305291.5303979628267.470+37%3110871243.533+75%3111130717.668+75%2239951265.401+143%1419638926.706+283%
Usd Price Per Share119.150-12%134.010105.160+27%89.560+50%86.838+54%63.052+113%40.082+234%
Usd Profit--34907000.00017915500.000+95%750000.000+4554%4739916.667+636%-1041000.000+103%-3422191.176+110%
Usd Revenue--157370000.000132823000.000+18%89689750.000+75%86760666.667+81%56125450.000+180%34650352.941+354%
Usd Total Gains Per Share--1.1710.615+90%0.280+318%0.529+121%0.225+420%0.231+408%
 EOD+4 -4MRQTTM+33 -5YOY+35 -33Y+30 -85Y+29 -910Y+31 -7

3.3 Fundamental Score

Let's check the fundamental score of TransMedics Group Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.611
Price to Book Ratio (EOD)Between0-115.192
Net Profit Margin (MRQ)Greater than00.222
Operating Margin (MRQ)Greater than00.252
Quick Ratio (MRQ)Greater than18.927
Current Ratio (MRQ)Greater than19.857
Debt to Asset Ratio (MRQ)Less than10.643
Debt to Equity Ratio (MRQ)Less than11.799
Return on Equity (MRQ)Greater than0.150.110
Return on Assets (MRQ)Greater than0.050.039
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of TransMedics Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.646
Ma 20Greater thanMa 50113.782
Ma 50Greater thanMa 100116.013
Ma 100Greater thanMa 200118.521
OpenGreater thanClose115.250
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Fundamental data was last updated by Penke on 2025-09-05 09:51:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Transmedics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Transmedics to theย Medical Devices industry mean.
  • A Net Profit Margin of 22.2%ย means thatย $0.22 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TransMedics Group Inc:

  • The MRQ is 22.2%. The company is making a huge profit. +2
  • The TTM is 12.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ22.2%TTM12.4%+9.8%
TTM12.4%YOY-2.5%+14.9%
TTM12.4%5Y-45.6%+58.0%
5Y-45.6%10Y-107.2%+61.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ22.2%-10.9%+33.1%
TTM12.4%-10.1%+22.5%
YOY-2.5%-15.1%+12.6%
3Y-1.6%-13.9%+12.3%
5Y-45.6%-13.0%-32.6%
10Y-107.2%-12.2%-95.0%
4.3.1.2. Return on Assets

Shows howย efficientย Transmedics is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Transmedics to theย Medical Devices industry mean.
  • 3.9% Return on Assets means thatย Transmedics generatedย $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TransMedics Group Inc:

  • The MRQ is 3.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.9%TTM2.1%+1.8%
TTM2.1%YOY0.0%+2.1%
TTM2.1%5Y-2.8%+4.9%
5Y-2.8%10Y-5.2%+2.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%-1.7%+5.6%
TTM2.1%-2.1%+4.2%
YOY0.0%-3.3%+3.3%
3Y0.2%-3.1%+3.3%
5Y-2.8%-2.5%-0.3%
10Y-5.2%-3.1%-2.1%
4.3.1.3. Return on Equity

Shows how efficient Transmedics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Transmedics to theย Medical Devices industry mean.
  • 11.0% Return on Equity means Transmedics generated $0.11ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TransMedics Group Inc:

  • The MRQ is 11.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.0%TTM6.4%+4.6%
TTM6.4%YOY-0.8%+7.2%
TTM6.4%5Y-4.7%+11.1%
5Y-4.7%10Y-15.8%+11.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0%-2.0%+13.0%
TTM6.4%-2.1%+8.5%
YOY-0.8%-4.0%+3.2%
3Y1.1%-4.4%+5.5%
5Y-4.7%-4.4%-0.3%
10Y-15.8%-5.8%-10.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of TransMedics Group Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Transmedics is operatingย .

  • Measures how much profit Transmedics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Transmedics to theย Medical Devices industry mean.
  • An Operating Margin of 25.2%ย means the company generated $0.25 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TransMedics Group Inc:

  • The MRQ is 25.2%. The company is operating very efficient. +2
  • The TTM is 14.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ25.2%TTM14.6%+10.6%
TTM14.6%YOY-0.5%+15.2%
TTM14.6%5Y-39.5%+54.1%
5Y-39.5%10Y-97.6%+58.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ25.2%-19.0%+44.2%
TTM14.6%-13.7%+28.3%
YOY-0.5%-17.0%+16.5%
3Y1.0%-13.7%+14.7%
5Y-39.5%-11.5%-28.0%
10Y-97.6%-16.2%-81.4%
4.3.2.2. Operating Ratio

Measures how efficient Transmedics is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Medical Devices industry mean).
  • An Operation Ratio of 0.77 means that the operating costs are $0.77 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TransMedics Group Inc:

  • The MRQ is 0.768. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.867. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.768TTM0.867-0.100
TTM0.867YOY1.039-0.172
TTM0.8675Y1.405-0.538
5Y1.40510Y1.970-0.565
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7681.309-0.541
TTM0.8671.308-0.441
YOY1.0391.221-0.182
3Y1.0101.299-0.289
5Y1.4051.314+0.091
10Y1.9701.322+0.648
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of TransMedics Group Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Transmedics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Medical Devices industry mean).
  • A Current Ratio of 9.86ย means the company has $9.86 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TransMedics Group Inc:

  • The MRQ is 9.857. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.864. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.857TTM8.864+0.993
TTM8.864YOY9.831-0.967
TTM8.8645Y9.719-0.854
5Y9.71910Y7.343+2.375
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8572.474+7.383
TTM8.8642.594+6.270
YOY9.8312.691+7.140
3Y10.6162.885+7.731
5Y9.7193.528+6.191
10Y7.3433.426+3.917
4.4.3.2. Quick Ratio

Measures if Transmedics is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Transmedics to theย Medical Devices industry mean.
  • A Quick Ratio of 8.93ย means the company can pay off $8.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TransMedics Group Inc:

  • The MRQ is 8.927. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.827. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.927TTM7.827+1.100
TTM7.827YOY8.763-0.937
TTM7.8275Y10.747-2.920
5Y10.74710Y8.349+2.398
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9271.350+7.577
TTM7.8271.553+6.274
YOY8.7631.706+7.057
3Y9.5681.896+7.672
5Y10.7472.225+8.522
10Y8.3492.519+5.830
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of TransMedics Group Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Transmedicsย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Transmedics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.64ย means that Transmedics assets areย financed with 64.3% credit (debt) and the remaining percentage (100% - 64.3%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of TransMedics Group Inc:

  • The MRQ is 0.643. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.693. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.643TTM0.693-0.051
TTM0.693YOY0.788-0.095
TTM0.6935Y0.550+0.144
5Y0.55010Y0.541+0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6430.408+0.235
TTM0.6930.414+0.279
YOY0.7880.400+0.388
3Y0.6400.397+0.243
5Y0.5500.420+0.130
10Y0.5410.456+0.085
4.5.4.2. Debt to Equity Ratio

Measures ifย Transmedics is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Transmedics to theย Medical Devices industry mean.
  • A Debt to Equity ratio of 179.9% means that company has $1.80 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TransMedics Group Inc:

  • The MRQ is 1.799. The company is just able to pay all its debts with equity.
  • The TTM is 2.301. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.799TTM2.301-0.502
TTM2.301YOY3.782-1.481
TTM2.3015Y1.777+0.524
5Y1.77710Y1.912-0.135
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7990.631+1.168
TTM2.3010.646+1.655
YOY3.7820.599+3.183
3Y2.4600.640+1.820
5Y1.7770.649+1.128
10Y1.9120.769+1.143
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Transmedics generates.

  • Above 15 is considered overpriced butย always compareย Transmedics to theย Medical Devices industry mean.
  • A PE ratio of 38.93 means the investor is paying $38.93ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TransMedics Group Inc:

  • The EOD is 34.611. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.927. Based on the earnings, the company is overpriced. -1
  • The TTM is 119.330. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD34.611MRQ38.927-4.317
MRQ38.927TTM119.330-80.403
TTM119.330YOY77.621+41.709
TTM119.3305Y-24.950+144.280
5Y-24.95010Y-17.576-7.374
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD34.611-1.102+35.713
MRQ38.927-1.233+40.160
TTM119.330-1.359+120.689
YOY77.621-2.949+80.570
3Y-24.853-1.780-23.073
5Y-24.950-2.182-22.768
10Y-17.576-2.300-15.276
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TransMedics Group Inc:

  • The EOD is 14.638. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 16.464. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 12.686. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.638MRQ16.464-1.826
MRQ16.464TTM12.686+3.778
TTM12.686YOY160.701-148.015
TTM12.6865Y10.589+2.097
5Y10.58910Y3.046+7.543
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD14.638-1.632+16.270
MRQ16.464-1.908+18.372
TTM12.686-1.813+14.499
YOY160.701-3.218+163.919
3Y35.713-2.227+37.940
5Y10.589-4.197+14.786
10Y3.046-4.006+7.052
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Transmedics is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Medical Devices industry mean).
  • A PB ratio of 17.09 means the investor is paying $17.09ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TransMedics Group Inc:

  • The EOD is 15.192. Based on the equity, the company is expensive. -2
  • The MRQ is 17.087. Based on the equity, the company is expensive. -2
  • The TTM is 15.866. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.192MRQ17.087-1.895
MRQ17.087TTM15.866+1.221
TTM15.866YOY19.623-3.757
TTM15.8665Y14.613+1.253
5Y14.61310Y10.146+4.467
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD15.1922.270+12.922
MRQ17.0872.126+14.961
TTM15.8662.196+13.670
YOY19.6232.681+16.942
3Y16.1562.683+13.473
5Y14.6133.672+10.941
10Y10.1464.161+5.985
4.6.2. Total Gains per Share

2.4. Latest News of TransMedics Group Inc

Does TransMedics Group Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from TransMedics Group Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-14
14:43
This TransMedics Group Insider Increased Their Holding In The Last YearRead
2025-09-13
00:49
Central Garden & Pet Breaks Below 200-Day Moving Average - Notable for CENTARead
2025-09-09
07:11
Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings MomentumRead
2025-08-21
20:03
Edwards Lifesciences Stock Pumps Up Its Relative Strength RatingRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TransMedics Group Inc.

4.8.1. Institutions holding TransMedics Group Inc

Institutions are holding 111.462% of the shares of TransMedics Group Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc15.39480.00745248129199420.3814
2025-03-31FMR Inc14.66110.0215499800999056224.718
2025-06-30Vanguard Group Inc10.54830.00783595957209610.5863
2025-03-31State Street Corp3.83260.00361306535-54724-4.0201
2025-03-31Macquarie Group Ltd3.27250.0981111559612309612.4026
2025-06-30Fidelity International Ltd3.09630.12081055553-170420-13.9008
2025-06-30UBS Asset Mgmt Americas Inc2.80340.0259955675-2157407-69.3013
2025-03-31Geode Capital Management, LLC2.32740.0042793409206652.6742
2025-03-31Driehaus Capital Management LLC2.28440.5051778754179132.3544
2025-03-31UBS Group AG2.17460.009274133515109325.5985
2025-06-30Hood River Capital Management LLC1.99431.2722679847-115924-14.5675
2025-03-31Eventide Asset Management, LLC1.98880.90886779812790.0412
2025-03-31Citadel Advisors Llc1.78850.0078609689376755161.7432
2025-03-31Morgan Stanley - Brokerage Accounts1.75730.002959906014462231.8244
2025-06-30Marshall Wace Asset Management Ltd1.60390.0825546787394340258.6735
2025-06-30Liontrust Investment Partners LLP1.53641.0045523748-30609-5.5215
2025-06-30Brown Capital Management, LLC1.3241.7593451371-16752-3.5785
2025-03-31Amvescap Plc.1.30260.0057444063-234565-34.5646
2025-06-30Emerald Advisers, LLC1.28872.1579439329-15465-3.4004
2025-03-31JPMorgan Chase & Co1.210.00241249715567160.6134
Total 76.18998.007225973324-379967-1.5%

4.9.2. Funds holding TransMedics Group Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31iShares Core S&P Small-Cap ETF5.92620.299820202512940.0146
2025-07-31Vanguard Total Stock Mkt Idx Inv2.95560.00631007578-21248-2.0653
2025-07-31iShares Russell 2000 ETF2.29670.1536782945-14910-1.8688
2025-07-31Vanguard Small Cap Index2.28760.0595779868-5612-0.7145
2025-06-30Fidelity1.8951.020164600000
2025-06-30Fidelity Advisor New Insights I1.87120.36563790000
2025-05-31Fidelity Small Cap Growth1.85881.169963366300
2025-06-30Fidelity VIP Contrafund Initial1.80170.303861420000
2025-06-30Macquarie Small Cap Core I1.80131.1504614068-49817-7.5039
2025-06-30Fidelity VIP Mid Cap Initial1.50190.9342512000-25400-4.7265
2025-03-31Eventide Gilead N1.35141.235246068400
2025-07-31Vanguard Small Cap Growth Index Inv1.29130.1374440208-340-0.0772
2025-06-30Hood River Small-Cap Growth Instl1.0721.2542365464-81049-18.1515
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr1.06710.0539363774-158085-30.2927
2025-06-30Fidelity OTC1.06690.1543363712-156-0.0429
2025-06-30Fidelity Small Cap Index0.97860.174933359310950.3293
2025-05-31Fidelity Small Cap Growth K60.89431.123530485500
2025-07-31iShares S&P Small-Cap 600 Growth ETF0.86790.585529586600
2025-07-31SPDRยฎ Portfolio S&P 600โ„ข Sm Cap ETF0.86010.30022932041620.0553
2025-07-31iShares Russell 2000 Growth ETF0.8580.297729248800
Total 34.503610.779411762321-355066-3.0%

5.3. Insider Transactions

Insiders are holding 3.01% of the shares of TransMedics Group Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-09Anil P RanganathSELL686139.8
2025-05-27Edward M BasileSELL5000126.45
2025-05-23David WeillSELL732123.88
2025-05-09Edward M BasileSELL6000115.63
2024-12-02Tamer I KhayalSELL108486.4
2024-11-05Edward M BasileSELL675083.55
2024-10-15Waleed H HassaneinSELL8625132.71
2024-10-01Tamer I KhayalSELL2958148.24
2024-09-16Waleed H HassaneinSELL8625153.42
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Accumulated Other Comprehensive Income  -2374-233-131-36437-32742598



5.2. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets890,522
Total Liabilities572,421
Total Stockholder Equity318,101
 As reported
Total Liabilities 572,421
Total Stockholder Equity+ 318,101
Total Assets = 890,522

Assets

Total Assets890,522
Total Current Assets558,129
Long-term Assets332,393
Total Current Assets
Cash And Cash Equivalents 400,575
Net Receivables 104,851
Inventory 38,868
Other Current Assets 13,835
Total Current Assets  (as reported)558,129
Total Current Assets  (calculated)558,129
+/-0
Long-term Assets
Property Plant Equipment 318,073
Goodwill 11,549
Intangible Assets 2,050
Long-term Assets Other 221
Long-term Assets  (as reported)332,393
Long-term Assets  (calculated)331,893
+/- 500

Liabilities & Shareholders' Equity

Total Current Liabilities56,620
Long-term Liabilities515,801
Total Stockholder Equity318,101
Total Current Liabilities
Short-term Debt 3,021
Accounts payable 9,539
Other Current Liabilities 42,490
Total Current Liabilities  (as reported)56,620
Total Current Liabilities  (calculated)55,050
+/- 1,570
Long-term Liabilities
Long term Debt 510,889
Capital Lease Obligations Min Short Term Debt4,912
Long-term Liabilities  (as reported)515,801
Long-term Liabilities  (calculated)515,801
+/-0
Total Stockholder Equity
Common Stock725,655
Retained Earnings -407,652
Accumulated Other Comprehensive Income 98
Total Stockholder Equity (as reported)318,101
Total Stockholder Equity (calculated)318,101
+/-0
Other
Capital Stock725,655
Cash and Short Term Investments 400,575
Common Stock Shares Outstanding 40,559
Current Deferred Revenue1,570
Liabilities and Stockholders Equity 890,522
Net Debt 118,247
Net Invested Capital 828,990
Net Working Capital 501,509
Property Plant and Equipment Gross 371,850
Short Long Term Debt Total 518,822



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
0
0
0
37,001
0
51,134
48,397
42,157
38,759
121,014
112,618
105,299
96,923
163,137
159,322
152,026
145,783
140,512
131,146
134,893
124,008
117,285
274,873
277,147
287,088
690,358
689,227
706,047
723,831
758,577
785,571
804,076
837,530
890,522
890,522837,530804,076785,571758,577723,831706,047689,227690,358287,088277,147274,873117,285124,008134,893131,146140,512145,783152,026159,322163,13796,923105,299112,618121,01438,75942,15748,39751,134037,001000
   > Total Current Assets 
47,838
0
0
34,036
24,663
47,477
43,081
34,794
30,059
116,133
107,366
100,001
91,704
158,227
154,126
146,766
140,543
135,052
125,577
118,705
105,795
95,113
250,586
252,294
261,730
662,655
536,724
510,654
488,306
509,265
492,475
497,216
505,918
558,129
558,129505,918497,216492,475509,265488,306510,654536,724662,655261,730252,294250,58695,113105,795118,705125,577135,052140,543146,766154,126158,22791,704100,001107,366116,13330,05934,79443,08147,47724,66334,0360047,838
       Cash And Cash Equivalents 
-47,838
0
0
11,936
-24,663
34,439
28,890
20,241
12,215
47,242
20,407
20,092
24,738
51,152
21,397
24,581
26,727
25,314
22,495
25,580
17,897
30,386
204,462
201,182
195,375
582,210
427,110
394,812
350,217
362,751
330,094
336,650
310,143
400,575
400,575310,143336,650330,094362,751350,217394,812427,110582,210195,375201,182204,46230,38617,89725,58022,49525,31426,72724,58121,39751,15224,73820,09220,40747,24212,21520,24128,89034,439-24,66311,93600-47,838
       Short-term Investments 
95,676
0
0
12,727
49,326
750
0
0
0
48,995
67,865
60,596
47,816
88,223
111,317
101,061
91,386
86,935
80,360
66,872
54,104
27,697
0
0
0
0
0
0
0
0
0
0
0
0
00000000000027,69754,10466,87280,36086,93591,386101,061111,31788,22347,81660,59667,86548,99500075049,32612,7270095,676
       Net Receivables 
0
0
0
925
0
2,748
3,904
3,438
5,146
7,105
6,465
6,559
6,133
4,431
6,141
6,864
7,395
6,271
4,150
5,934
11,724
12,979
22,035
27,611
38,620
47,524
60,654
63,576
81,942
81,158
90,128
97,722
142,026
104,851
104,851142,02697,72290,12881,15881,94263,57660,65447,52438,62027,61122,03512,97911,7245,9344,1506,2717,3956,8646,1414,4316,1336,5596,4657,1055,1463,4383,9042,7480925000
       Other Current Assets 
0
0
0
477
0
535
666
3,676
2,808
3,142
4,186
3,076
3,312
3,732
4,374
4,652
3,215
3,525
7,306
5,460
10,712
13,166
11,028
2,896
3,774
2,376
9,595
8,031
7,606
16,685
20,101
16,290
10,369
13,835
13,83510,36916,29020,10116,6857,6068,0319,5952,3763,7742,89611,02813,16610,7125,4607,3063,5253,2154,6524,3743,7323,3123,0764,1863,1422,8083,6766665350477000
   > Long-term Assets 
-47,838
0
0
2,965
-24,663
3,657
5,316
7,363
8,700
4,881
5,252
5,298
5,219
4,910
5,196
5,260
5,240
5,460
5,569
16,188
18,213
22,172
24,287
24,853
25,358
27,703
152,503
195,393
235,525
249,312
293,096
306,860
331,612
332,393
332,393331,612306,860293,096249,312235,525195,393152,50327,70325,35824,85324,28722,17218,21316,1885,5695,4605,2405,2605,1964,9105,2195,2985,2524,8818,7007,3635,3163,657-24,6632,96500-47,838
       Property Plant Equipment 
0
0
0
2,459
0
3,151
3,342
3,474
3,750
4,375
4,746
4,792
4,713
4,404
4,690
4,754
4,734
4,954
5,063
15,688
17,713
21,672
23,787
24,353
24,100
26,894
137,865
180,487
220,647
234,926
278,682
292,451
317,251
318,073
318,073317,251292,451278,682234,926220,647180,487137,86526,89424,10024,35323,78721,67217,71315,6885,0634,9544,7344,7544,6904,4044,7134,7924,7464,3753,7503,4743,3423,15102,459000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,673
11,990
11,990
11,549
11,549
11,549
11,549
11,549
11,54911,54911,54911,54911,54911,99011,99011,67300000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,405
2,354
2,303
2,253
2,202
2,152
2,101
2,050
2,0502,1012,1522,2022,2532,3032,3542,40500000000000000000000000000
       Long-term Assets Other 
-47,838
0
0
506
-24,663
506
1,974
3,889
4,950
506
506
506
506
506
506
506
506
506
6
500
500
500
500
500
508
59
560
62
85
84
663
708
711
221
2217117086638485625605950850050050050050065065065065065065065065065064,9503,8891,974506-24,66350600-47,838
> Total Liabilities 
0
0
0
18,853
0
43,681
45,799
46,982
51,278
49,853
49,146
50,650
50,240
49,377
49,772
48,135
48,108
51,529
52,597
67,039
64,098
66,366
87,016
89,772
94,463
545,145
562,767
568,845
564,360
568,683
575,651
575,473
571,222
572,421
572,421571,222575,473575,651568,683564,360568,845562,767545,14594,46389,77287,01666,36664,09867,03952,59751,52948,10848,13549,77249,37750,24050,65049,14649,85351,27846,98245,79943,681018,853000
   > Total Current Liabilities 
0
0
0
10,899
0
9,273
11,359
12,553
16,201
15,377
14,641
16,115
15,039
13,818
13,624
11,879
11,757
15,079
15,923
23,238
20,256
22,741
20,689
23,661
28,635
32,017
49,101
54,934
50,223
54,329
60,048
59,913
55,603
56,620
56,62055,60359,91360,04854,32950,22354,93449,10132,01728,63523,66120,68922,74120,25623,23815,92315,07911,75711,87913,62413,81815,03916,11514,64115,37716,20112,55311,3599,273010,899000
       Short-term Debt 
0
0
0
1,805
0
0
0
0
0
0
0
0
0
0
0
0
34,787
34,921
0
8,604
2,674
2,744
2,814
1,444
2,962
3,760
3,970
4,070
2,086
4,278
5,086
2,727
2,791
3,021
3,0212,7912,7275,0864,2782,0864,0703,9703,7602,9621,4442,8142,7442,6748,604034,92134,7870000000000001,805000
       Accounts payable 
0
0
0
3,515
0
2,742
3,689
4,720
5,499
6,662
4,766
7,247
4,860
3,722
778
1,206
1,289
2,389
2,682
6,651
2,934
5,711
3,080
3,341
4,329
7,031
12,836
12,717
9,225
13,027
13,134
10,292
10,595
9,539
9,53910,59510,29213,13413,0279,22512,71712,8367,0314,3293,3413,0805,7112,9346,6512,6822,3891,2891,2067783,7224,8607,2474,7666,6625,4994,7203,6892,74203,515000
       Other Current Liabilities 
0
0
0
5,579
0
6,531
7,670
7,527
10,343
8,540
9,713
8,702
10,015
9,076
11,499
10,410
10,036
12,217
12,921
16,337
14,401
14,048
14,569
18,635
21,100
20,982
29,666
36,186
36,852
35,577
39,644
45,152
40,139
42,490
42,49040,13945,15239,64435,57736,85236,18629,66620,98221,10018,63514,56914,04814,40116,33712,92112,21710,03610,41011,4999,07610,0158,7029,7138,54010,3437,5277,6706,53105,579000
   > Long-term Liabilities 
0
0
0
7,954
0
34,408
34,440
34,429
35,077
34,476
34,505
34,535
35,201
35,559
36,148
36,256
36,351
36,450
36,674
43,801
43,842
43,625
66,327
66,111
65,828
513,128
513,666
513,911
514,137
514,354
515,603
515,560
515,619
515,801
515,801515,619515,560515,603514,354514,137513,911513,666513,12865,82866,11166,32743,62543,84243,80136,67436,45036,35136,25636,14835,55935,20134,53534,50534,47635,07734,42934,44034,40807,954000
       Long term Debt Total 
0
0
0
0
0
0
0
33,670
33,785
33,902
34,023
34,146
34,269
0
0
34,657
34,787
34,921
35,058
35,197
35,334
35,475
58,540
0
58,802
0
0
0
0
0
0
0
0
0
00000000058,802058,54035,47535,33435,19735,05834,92134,78734,6570034,26934,14634,02333,90233,78533,6700000000
       Other Liabilities 
0
0
0
0
0
963
876
759
667
574
482
389
932
1,164
1,623
1,599
1,564
1,529
1,616
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,6161,5291,5641,5991,6231,16493238948257466775987696300000
       Deferred Long Term Liability 
0
0
0
0
0
0
1,468
3,383
4,444
0
0
0
0
0
0
1,599
1,564
1,529
1,616
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,6161,5291,5641,5990000004,4443,3831,468000000
> Total Stockholder Equity
38,789
0
0
18,148
18,148
7,453
2,598
-4,825
-12,519
71,161
63,472
54,649
46,683
113,760
109,550
103,891
97,675
88,983
78,549
67,854
59,910
50,919
187,857
187,375
192,625
145,213
126,460
137,202
159,471
189,894
209,920
228,603
266,308
318,101
318,101266,308228,603209,920189,894159,471137,202126,460145,213192,625187,375187,85750,91959,91067,85478,54988,98397,675103,891109,550113,76046,68354,64963,47271,161-12,519-4,8252,5987,45318,14818,1480038,789
   Common Stock
0
0
0
1
0
1
1
331,212
1
423,245
423,758
424,134
424,791
500,556
501,486
502,217
503,912
505,933
508,458
510,488
513,203
515,756
660,061
666,277
674,156
627,747
634,458
641,106
651,161
669,445
685,251
697,208
709,194
725,655
725,655709,194697,208685,251669,445651,161641,106634,458627,747674,156666,277660,061515,756513,203510,488508,458505,933503,912502,217501,486500,556424,791424,134423,758423,2451331,2121101000
   Retained Earnings -407,652-442,559-468,241-475,098-479,314-491,508-503,705-507,736-482,314-481,313-478,677-471,957-464,531-453,008-442,446-429,778-416,816-406,148-398,231-391,920-386,832-378,335-369,483-360,306-352,026-342,831-335,936-328,301-323,1960-312,180000
   Capital Surplus 
0
0
0
0
0
0
0
143,794
143,859
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000143,859143,7940000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
143,604
0
143,686
143,741
143,794
515,647
-121,014
-112,618
-2
227
36
-16
0
-89
-134
-131
68,042
-285
-306
-247
-225
-218
0
0
0
0
0
-265,411
228,967
0
0
00228,967-265,41100000-218-225-247-306-28568,042-131-134-890-1636227-2-112,618-121,014515,647143,794143,741143,6860143,604000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue441,540
Cost of Revenue-179,459
Gross Profit262,081262,081
 
Operating Income (+$)
Gross Profit262,081
Operating Expense-224,585
Operating Income37,49637,496
 
Operating Expense (+$)
Research Development55,968
Selling General Administrative168,617
Selling And Marketing Expenses0
Operating Expense224,585224,585
 
Net Interest Income (+$)
Interest Income0
Interest Expense-14,409
Other Finance Cost-0
Net Interest Income-14,409
 
Pretax Income (+$)
Operating Income37,496
Net Interest Income-14,409
Other Non-Operating Income Expenses0
Income Before Tax (EBT)35,78039,212
EBIT - interestExpense = 35,780
35,780
49,873
Interest Expense14,409
Earnings Before Interest and Taxes (EBIT)50,18950,189
Earnings Before Interest and Taxes (EBITDA)69,947
 
After tax Income (+$)
Income Before Tax35,780
Tax Provision-316
Net Income From Continuing Ops35,46435,464
Net Income35,464
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses404,044
Total Other Income/Expenses Net-1,71614,409
 

Technical Analysis of Transmedics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Transmedics. The general trend of Transmedics is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Transmedics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Transmedics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TransMedics Group Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 133.54 < 136.63 < 145.50.

The bearish price targets are: 101.00 > 98.89 > 98.88.

Know someone who trades $TMDX? Share this with them.๐Ÿ‘‡

TransMedics Group Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TransMedics Group Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TransMedics Group Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TransMedics Group Inc. The current macd is -1.40979391.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Transmedics price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Transmedics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Transmedics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
TransMedics Group Inc Daily Moving Average Convergence/Divergence (MACD) ChartTransMedics Group Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TransMedics Group Inc. The current adx is 18.69.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Transmedics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
TransMedics Group Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TransMedics Group Inc. The current sar is 103.71.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
TransMedics Group Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TransMedics Group Inc. The current rsi is 55.65. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
TransMedics Group Inc Daily Relative Strength Index (RSI) ChartTransMedics Group Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TransMedics Group Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Transmedics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
TransMedics Group Inc Daily Stochastic Oscillator ChartTransMedics Group Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TransMedics Group Inc. The current cci is 57.60.

TransMedics Group Inc Daily Commodity Channel Index (CCI) ChartTransMedics Group Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TransMedics Group Inc. The current cmo is 23.27.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
TransMedics Group Inc Daily Chande Momentum Oscillator (CMO) ChartTransMedics Group Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TransMedics Group Inc. The current willr is -1.89189189.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
TransMedics Group Inc Daily Williams %R ChartTransMedics Group Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of TransMedics Group Inc.

TransMedics Group Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TransMedics Group Inc. The current atr is 5.90494168.

TransMedics Group Inc Daily Average True Range (ATR) ChartTransMedics Group Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TransMedics Group Inc. The current obv is -15,874,280.

TransMedics Group Inc Daily On-Balance Volume (OBV) ChartTransMedics Group Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TransMedics Group Inc. The current mfi is 47.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TransMedics Group Inc Daily Money Flow Index (MFI) ChartTransMedics Group Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TransMedics Group Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

TransMedics Group Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TransMedics Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.646
Ma 20Greater thanMa 50113.782
Ma 50Greater thanMa 100116.013
Ma 100Greater thanMa 200118.521
OpenGreater thanClose115.250
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Transmedics with someone you think should read this too:
  • Are you bullish or bearish on Transmedics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Transmedics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TransMedics Group Inc

I send you an email if I find something interesting about TransMedics Group Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TransMedics Group Inc.

Receive notifications about TransMedics Group Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.